Data / Research funding / Anthrax
Anthrax: 26 NIH awards ($38.9M) to 18 organizations
26 NIH awards ($38.9M) in the NIH spending category Anthrax, to 18 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
26 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,892,629 | September 15, 2004 | August 31, 2025 | FARRIS, A DARISE | reporter.nih.gov |
| Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $6,593,067 | September 16, 2021 | February 28, 2025 | ADAMS, ERIN JUNE | reporter.nih.gov |
| Development of an Anthrax Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $2,562,540 | September 25, 2008 | July 7, 2021 | PARK, SUKJOON | reporter.nih.gov |
| Pathobiology of heme inducible transporters in Gram positive pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,512,855 | December 5, 2008 | April 30, 2027 | SKAAR, ERIC P | reporter.nih.gov |
| Development of a Therapeutic to Treat Anthrax in Humans | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,209,062 | September 21, 2018 | April 30, 2024 | JOHNSON, ALAN | reporter.nih.gov |
| Virus-Like Nanoparticles for Non-Capsid Antigen Delivery with Virus Structure/Functional Mimicry to Activate B Cell Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,052,840 | July 7, 2020 | June 30, 2025 | SUN, DUXIN | reporter.nih.gov |
| Teixobactin Development for Anthrax | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,989,172 | June 15, 2020 | May 31, 2024 | HUGHES, DALLAS | reporter.nih.gov |
| Mechanisms of anthrax lethal toxin-induced mortality and the novel biological-based targeted therapies | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,810,078 | January 17, 2023 | December 31, 2027 | LIU, SHIHUI | reporter.nih.gov |
| Task B11: Sample Storage to Support a Label Change for Amoxicillin and Amoxicillin-Clavulanate | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,669,454 | October 31, 2023 | October 30, 2024 | reporter.nih.gov | |
| Surface Proteins of Bacillus anthracis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,608,888 | January 1, 2007 | June 30, 2027 | MISSIAKAS, DOMINIQUE | reporter.nih.gov |
| Development of Monoclonal Antibody Therapeutics for Anthrax | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $1,448,422 | September 1, 2008 | August 31, 2012 | JOHNSON, VIRGINIA G. | reporter.nih.gov |
| An epitope-focused nanoparticle vaccine for anthrax | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $983,698 | May 1, 2019 | May 31, 2025 | WHITACRE, DAVID C | reporter.nih.gov |
| Preclinical development of Novo29, a new antibiotic | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $977,463 | January 10, 2018 | March 31, 2023 | LING, LOSEE LUCY | reporter.nih.gov |
| Nutrient Uptake during Anthrax Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $792,500 | June 21, 2012 | October 31, 2023 | MARESSO, ANTHONY W | reporter.nih.gov |
| Development of Human Anthrax Immune Globulin | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $749,260 | September 28, 2007 | December 31, 2011 | ROBERT, HOPKINS | reporter.nih.gov |
| Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $663,271 | February 15, 2017 | January 24, 2023 | ADHIKARI, RAJAN P | reporter.nih.gov |
| DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $545,686 | August 28, 2014 | February 29, 2024 | LEMIALE, LAURENCE | reporter.nih.gov |
| Bacterial Cholesterol-Dependent Cytolysins in Inflammasome Activation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $506,394 | January 24, 2025 | December 31, 2029 | CHEN, JUEQI | reporter.nih.gov |
| Identification and characterization of a comprehensive set of factors required for sporulation and germination in Bacillus anthracis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $466,063 | June 1, 2022 | May 14, 2025 | RUDNER, DAVID Z | reporter.nih.gov |
| Molecular mechanisms of anthrax toxin unfolding and translocation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $424,573 | September 9, 2025 | August 31, 2027 | KRANTZ, BRYAN ANDREW | reporter.nih.gov |
| Describing the stable, non-covalent BclA-BxpB attachment in B. anthracis spores | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $402,806 | May 14, 2024 | March 31, 2027 | TURNBOUGH, CHARLES LEE | reporter.nih.gov |
| Multiscale Modeling of B. Anthracis Surface Layer Assembly and Depolymerization by Nanobodies | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $393,078 | May 1, 2022 | April 30, 2025 | PAK, ALEXANDER | reporter.nih.gov |
| Small Regulatory RNA Function in Bacillus anthracis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $230,742 | February 19, 2020 | July 31, 2022 | KOEHLER, THERESA M. | reporter.nih.gov |
| Immune responses to commensal bacterial spores in the intestinal mucosa | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $206,773 | May 22, 2020 | July 31, 2022 | PARK, JIN MO | reporter.nih.gov |
| Role of Ca2+ in B. anthracis exosporium assembly | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $148,500 | August 1, 2025 | July 31, 2027 | TURNBOUGH, CHARLES LEE | reporter.nih.gov |
| The regulatory role of an RNA binding protein in two-component signaling and its impact on cellular physiology and anthrax pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $71,062 | July 1, 2021 | June 30, 2022 | PI, HUALIANG | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 7 | $2,749,510 | 0 | $0 |
| 2024 | 6 | $2,248,847 | 0 | $0 |
| 2023 | 10 | $8,343,107 | 0 | $0 |
| 2022 | 10 | $9,048,544 | 0 | $0 |
| 2021 | 18 | $16,520,868 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 20 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 20 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 20 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.